Health tech deserves real evidence
Augura combines biostatistician expertise with an AI-powered agentic platform to generate the clinical and operational evidence digital health and MedTech companies need to get published, certified, and scale. In weeks, not months.

Innovation gets you to market
Evidence gets you adopted
MedTech and digital health innovators struggle to generate the clinical and health economics evidence that payers, health systems, and investors require.
Payers won't reimburse without proof of real-world efficacy. Hospitals won't sign without peer-reviewed studies. Investors increasingly require evidence of real-world impact, not just user growth.
That's why we built Augura.
Custom-built for
health tech innovators
Six ways Augura
moves you closer to success
Earn scientific proof to sign hospitals and institutions
Get peer-reviewed studies published. With your team's name on the paper, you enter the scientific community and give institutions the proof they need to work with you.

AI-powered, built for speed,
without compromising rigor

Weeks,
not months
What traditionally takes 12–18 months, Augura delivers in weeks, with the same scientific rigor.

AI-powered,
end-to-end
A fully agentic platform, from data intake to published study and continuous monitoring.

Experts
in the loop
World-class biostatistician expertise embedded at every step. Reproducible, traceable, defensible.
Our founding team,
experts in clinical research

Romain Pirracchio, MD MPH PhD
Founder
Inaugural Ronald D. Miller Distinguished Professor at UCSF. Executive Vice Chair for Anesthesia at UCSF. Associate and Statistical AI Editor at JAMA. Physician & biostatistician (PhD Biostatistics; MPH Harvard). Leads a joint UCSF–UC Berkeley research lab on AI and causal inference. 240+ peer-reviewed publications.

Matthieu Legrand, MD PhD
Founder
Tenured Professor of Medicine and Director of Clinical Research at UCSF. World-leading expert in critical care. 300+ publications in NEJM, JAMA, The Lancet. Led multiple randomized controlled trials.

Francois Cottin, MBA
Founder, CEO
Twenty years building and scaling technology companies. Former founder, BCG consultant, and Senior Director at Adobe leading enterprise go-to-market including AI/ML products. Built Augura because the evidence gap is an infrastructure problem to solve.






